Xudong Yao

27PUBLICATIONS
64CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer cell biologyProteomics and metabolomicsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Sep 02, 2026
MYC-Sensitized Cuproptosis Combined With PTT to Remodel the Immune Microenvironment of Prostate Cancer.

|Aug 06, 2026
Lactobacillus plantarum-derived indole-3-lactic acid inhibits prostate cancer progression through ASF1B/ENO1 axis and remodels the tumor microenvironment to enhance anti-PD-1 therapy.

|Jan 09, 2026
Pseudomonas aeruginosa Exacerbates Bladder Cancer Progression by Activating Cancer-Driven Immunosuppression.

Fuhan Yang, Wentao Zhang, Ruiliang Wang

|Dec 29, 2025
ADAMTS9-AS2 Disrupts Docetaxel-Resistance in Castration-Resistant Prostate Cancer via Stemness Suppression and Ferroptosis Induction.

Ji Liu, Yan Gao, Yadong Guo

|Oct 29, 2025
Correction: Zhang et al. An Integrated Approach Utilizing Single-Cell and Bulk RNA-Sequencing for the Identification of a Mitophagy-Associated Genes Signature: Implications for Prognostication and Therapeutic Stratification in Prostate Cancer. Biomedicines 2025, 13, 311.

Yuke Zhang, Li Ding, Zhijin Zhang

|Oct 24, 2025
USP21/YBX1/HIF1-α promotes the progression of prostate cancer.

Zhuoran Gu, Libin Zou, Cheng Jiang

Pageof 5

Frequent Collaborators

8 joint publications

Ruiliang Wang

8 joint publications

Wentao Zhang

7 joint publications

Shiyu Mao

3 joint publications

Ji Liu